Theravance Biopharma (TBPH) Notes Initiation of Phase 3 Study of Closed Triple by GlaxoSmithKline and Innoviva
Tweet Send to a Friend
Theravance Biopharma, Inc. (NASDAQ: TBPH) announced that GlaxoSmithKline plc (GSK) and Innoviva, Inc. (Innoviva) have initiated a Phase 3 study ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
